Achieving adequate vascularization within implanted engineered tissues is a significant obstacle to maintaining viability and functionality. In vitro prevascularization of engineered tissues has been explored as a potential solution to this challenge. The traditional paradigm of in vitro prevascularization is to implant an engineered tissue with a preformed vascular network that is perfused after anastomosis with the host circulation. We investigated the efficacy of this strategy by implanting cell-dense prevascularized tissues created via cell-mediated contraction and composed of collagen and a collagen-fibrin mixture into dorsal window chambers surgically prepared on immunocompromised mice. We found that host-implant anastomosis takes place in 2–6 days and that perfusion of vessels within the implants is subsequently restricted by thrombosis. However, by day 7, a functional vascular network composed of host and implant vessels developed. Prevascularization enhanced intra-implant pO2 significantly as early as 2 days postimplantation, reaching a maximum of 55 mmHg by day 8, which was significantly greater than the maximum within cellularized control tissues (18 mmHg). By day 14, collagen tissues supported ∼0.51×109 implanted and host-derived cells per mL. Our findings elucidate key features of in vitro prevascularization that can be used toward the design of larger and more functionally complex engineered tissues.
Get full access to this article
View all access options for this article.
References
1.
MacneilS.Progress and opportunities for tissue-engineered skin. Nature, 445, 874, 2007.
2.
Ruano-RavinaA., and Jato DíazM.Autologous chondrocyte implantation: a systematic review. Osteoarthritis Cartilage, 14, 47, 2006.
3.
GroeberF., HoleiterM., HampelM., HindererS., and Schenke-LaylandK.Skin tissue engineering—in vivo and in vitro applications. Adv Drug Deliv Rev, 63, 352, 2011.
4.
ChungC., and BurdickJ.A.Engineering cartilage tissue. Adv Drug Deliv Rev, 60, 243, 2008.
RouwkemaJ., RivronN.C., and Van BlitterswijkC.A.Vascularization in tissue engineering. Trends Biotechnol, 26, 434, 2008.
7.
NovoselE.C., KleinhansC., and KlugerP.J.Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev, 63, 300, 2011.
8.
CarmelietP., and JainR.K.Angiogenesis in cancer and other diseases. Nature, 407, 249, 2000.
9.
HelmlingerG., YuanF., DellianM., and JainR.K.Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med, 3, 177, 1997.
10.
KannanR.Y., SalacinskiH.J., SalesK., ButlerP., and SeifalianA.M.The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials, 26, 1857, 2005.
11.
RichardsonT.P., PetersM.C., EnnettA.B., and MooneyD.J.Polymeric system for dual growth factor delivery. Nat Biotechnol, 19, 1029, 2001.
12.
LaschkeM.W., HarderY., AmonM., MartinI., FarhadiJ., RingA., Torio-PadronN., SchrammR., RückerM., JunkerD., HäufelJ.M., CarvalhoC., HebererM., GermannG., VollmarB., and MengerM.D.Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng, 12, 2093, 2006.
13.
LeeR.J., SpringerM.L., Blanco-BoseW.E., ShawR., UrsellP.C., and BlauH.M.VEGF gene delivery to myocardium. Circulation, 102, 898, 2000.
14.
JainR.K.Molecular regulation of vessel maturation. Nat Med, 9, 685, 2003.
15.
OttH.C., MatthiesenT.S., GohS.-K., BlackL.D., KrenS.M., NetoffT.I., and TaylorD.A.Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med, 14, 213, 2008.
16.
BadylakS.F., TaylorD., and UygunK.Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng, 13, 27, 2011.
17.
MillerJ.S., StevensK.R., YangM.T., BakerB.M., NguyenD.-H.T., CohenD.M., ToroE., ChenA.A., GalieP.A., YuX., ChaturvediR., BhatiaS.N., and ChenC.S.Rapid casting of patterned vascular networks for perfusable engineered three-dimensional tissues. Nat Mater, 11, 768, 2012.
18.
UygunB.E., Soto-GutierrezA., YagiH., IzamisM.-L., GuzzardiM.A., ShulmanC., MilwidJ., KobayashiN., TillesA., BerthiaumeF., HertlM., NahmiasY., YarmushM.L., and UygunK.Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med, 16, 814, 2010.
19.
ChiuL.L.Y., MontgomeryM., LiangY., LiuH., and RadisicM.Perfusable branching microvessel bed for vascularization of engineered tissues. Proc Natl Acad Sci U S A, 109, E3414, 2012.
20.
RiederE., KasimirM.-T., SilberhumerG., SeebacherG., WolnerE., SimonP., and WeigelG.Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Surg, 127, 399, 2004.
21.
LaschkeM.W., RückerM., JensenG., CarvalhoC., MülhauptR., GellrichN.-C., and MengerM.D.Improvement of vascularization of PLGA scaffolds by inosculation of in situ-preformed functional blood vessels with the host microvasculature. Ann Surg, 248, 939, 2008.
ChenX., AlediaA.S., GhajarC.M., GriffithC.K., PutnamA.J., HughesC.C.W., and GeorgeS.C.Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A, 15, 1363, 2008.
24.
ChenX., AlediaA.S., PopsonS.A., HimL., HughesC.C.W., and GeorgeS.C.Rapid anastomosis of endothelial progenitor cell–derived vessels with host vasculature is promoted by a high density of cotransplanted fibroblasts. Tissue Eng Part A, 16, 585, 2010.
25.
WhiteS.M., HingoraniR., AroraR.P.S., HughesC.C.W., GeorgeS.C., and ChoiB.Longitudinal in vivo imaging to assess blood flow and oxygenation in implantable engineered tissues. Tissue Eng Part C, 18, 697, 2012.
26.
RadisicM., EulothM., YangL., LangerR., FreedL.E., and Vunjak NovakovicG.High density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng, 82, 403, 2003.
27.
KimB.-S., PutnamA.J., KulikT.J., and MooneyD.J.Optimizing seeding and culture methods to engineer smooth muscle tissue on biodegradable polymer matrices. Biotechnol Bioeng, 57, 46, 1998.
28.
PapenfussH.D., GrossJ.F., IntagliettaM., and TreeseF.A.A transparent access chamber for the rat dorsal skin fold. Microvas Res, 18, 311, 1979.
29.
MoyA., WhiteS., IndrawanE., LotfiJ., NudelmanM., CostantiniS., AgarwalN., JiaW., KellyK., SorgB., and ChoiB.Wide-field functional imaging of blood flow and hemoglobin oxygen saturation in the rodent dorsal window chamber. Microvas Res, 82, 199, 2011.
30.
EsipovaT.V., KaragodovA., MillerJ., WilsonD.F., BuschT.M., and VinogradovS.A.Two new “protected” Oxyphors for biological oximetry: properties and application in tumor imaging. Anal Chem, 83, 8756, 2011.
31.
BoasD.A., and DunnA.K.Laser speckle contrast imaging in biomedical optics. J Biomed Opt, 15, 011109, 2010.
32.
ChoiB., KangN.M., and NelsonJ.S.Laser speckle imaging for monitoring blood flow dynamics in the in vivo rodent dorsal skin fold model. Microvas Res, 68, 143, 2004.
33.
FercherA.F., and BriersJ.D.Flow visualization by means of single-exposure speckle photography. Opt Commun, 37, 326, 1981.
34.
ChoiB., Ramirez-San-JuanJ.C., LotfiJ., and NelsonJ.S.Linear response range characterization and in vivo application of laser speckle imaging of blood flow dynamics. J Biomed Opt, 11, 041129, 2006.
35.
YuanS., DevorA., BoasD.A., and DunnA.K.Determination of optimal exposure time for imaging of blood flow changes with laser speckle contrast imaging. Appl Opt, 44, 1823, 2005.
36.
WhiteS.M., GeorgeS.C., and ChoiB.Automated computation of functional vascular density using laser speckle imaging in a rodent window chamber model. Microvasc Res, 82, 92, 2011.
37.
ParthasarathyA.B., TomW.J., GopalA., ZhangX., and DunnA.K.Robust flow measurement with multi-exposure speckle imaging. Opt Express, 16, 1975, 2008.
38.
BuiA.K., TevesK.M., IndrawanE., JiaW., and ChoiB.Longitudinal, multimodal functional imaging of microvascular response to photothermal therapy. Opt Lett, 35, 3216, 2010.
39.
KirkpatrickS.J., DuncanD.D., and Wells-GrayE.M.Detrimental effects of speckle-pixel size matching in laser speckle contrast imaging. J Biomed Opt, 33, 2886, 2008.
40.
Ramirez-San-JuanJ.C., Ramos-GarcíaR., Guizar-IturbideI., Martínez-NiconoffG., and ChoiB.Impact of velocity distribution assumption on simplified laser speckle imaging equation. Opt Express, 16, 3197, 2008.
41.
DunnA.K., BolayH., MoskowitzM.A., and BoasD.A.Dynamic imaging of cerebral blood flow using laser speckle. J Cereb Blood Flow Metab, 21, 195, 2001.
42.
WilsonD.F., LeeW.M.F., MakonnenS., AprelevaS., and VinogradovS.A.Oxygen pressures in the interstitial space of skeletal muscle and tumors in vivo. Adv Exp Med Biol, 614, 53, 2008.
43.
FlockS.T., JacquesS.L., WilsonB.C., StarW.M., and Van GemertM.J.C.Optical properties of Intralipid: a phantom medium for light propagation studies. Lasers Surg Med, 12, 510, 2005.
44.
KienleA., LilgeL.D., PattersonM.S., WilsonB.C., HibstR., and SteinerR.W.Investigation of multilayered tissue with in vivo reflectance measurements. International Symposium on Biomedical Optics Europe, Lille, France, 1994.
45.
HelmC.-L.E., ZischA., and SwartzM.A.Engineered blood and lymphatic capillaries in 3-D VEGF-fibrin-collagen matrices with interstitial flow. Biotechnol Bioeng, 96, 167, 2007.
46.
DvorakH.F., HarveyV.S., EstrellaP., BrownL.F., McdonaghJ., and DvorakA.M.Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest, 57, 673, 1987.
47.
CummingsC.L., GawlittaD., NeremR.M., and StegemannJ.P.Properties of engineered vascular constructs made from collagen, fibrin, and collagen–fibrin mixtures. Biomaterials, 25, 3699, 2004.
48.
RoweS.L., and StegemannJ.P.Interpenetrating collagen-fibrin composite matrices with varying protein contents and ratios. Biomacromolecules, 7, 2942, 2006.
49.
RaoR., PetersonA., CeccarelliJ., PutnamA., and StegemannJ.Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials. Angiogenesis, 15, 253, 2012.
50.
GhajarC.M., ChenX., HarrisJ.W., SureshV., HughesC.C.W., JeonN.L., PutnamA.J., and GeorgeS.C.The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys J, 94, 1930, 2008.
51.
MironovV., ViscontiR.P., KasyanovV., ForgacsG., DrakeC.J., and MarkwaldR.R.Organ printing: tissue spheroids as building blocks. Biomaterials, 30, 2164, 2009.
52.
ChienS.Shear dependence of effective cell volume as a determinant of blood viscosity. Science, 168, 977, 1970.
53.
EckmannD.M., BowersS., SteckerM., and CheungA.T.Hematocrit, volume expander, temperature, and shear rate effects on blood viscosity. Anesth Analg, 91, 539, 2000.
54.
LovettM., CannizzaroC., DaheronL., MessmerB., Vunjak-NovakovicG., and KaplanD.L.Silk fibroin microtubes for blood vessel engineering. Biomaterials, 28, 5271, 2007.
55.
MoyaM.L., HsuY.-H., LeeA.P., HughesC.C.W., and GeorgeS.C.In vitro perfused human capillary networks. Tissue Eng Part C. 730, 2013.
56.
FleckR.A., Vijaya MohanRao, L., RapaportS.I., and VarkiN.Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res, 57, 765, 1990.
57.
WilcoxJ.N., SmithK.M., SchwartzS.M., and GordonD.Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci U S A, 86, 2839, 1989.
58.
ClaussM., GerlachM., GerlachH., BrettJ., WangF., FamillettiP.C., PanY.C., OlanderJ.V., ConnollyD.T., and SternD.Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med, 172, 1535, 1990.
59.
AgenoW., GallusA.S., WittkowskyA., CrowtherM., HylekE.M., and PalaretiG.Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis: american college of chest physicians evidence-based clinical practice guidelines. Chest, 141, e44S, 2012.
60.
LesmanA., KofflerJ., AtlasR., BlinderY.J., KamZ., and LevenbergS.Engineering vessel-like networks within multicellular fibrin-based constructs. Biomaterials, 32, 7856, 2011.
61.
ChengG., LiaoS., WongH.K., LacorreD.A., Di TomasoE., AuP., FukumuraD., JainR.K., and MunnL.L.Engineered blood vessel networks connect to host vasculature via wrapping-and-tapping anastomosis. Blood, 118, 4740, 2011.
62.
O'brienP.J., MolinoM., KahnM., and BrassL.F.Protease activated receptors: theme and variations. Oncogene, 20, 1570, 2001.
63.
CoughlinS.R.Thrombin signalling and protease-activated receptors. Nature, 407, 258, 2000.
BanksR.E., ForbesM.A., KinseyS.E., StanleyA., InghamE., WaltersC., and SelbyP.J.Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer, 77, 956, 1998.
66.
EnglishD., WelchZ., KovalaA.T., HarveyK., VolpertO.V., BrindleyD.N., and GarciaJ.G.N.Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J, 14, 2255, 2000.
67.
DewhirstM.W., OngE.T., RosnerG.L., RehmusS.W., ShanS., BraunR.D., BrizelD.M., and SecombT.W.Arteriolar oxygenation in tumour and subcutaneous arterioles: effects of inspired air oxygen content. Br J Cancer, Suppl 27, S241, 1996.
68.
DewhirstM.W., OngE.T., KlitzmanB., SecombT.W., VinuyaR.Z., DodgeR., BrizelD., and GrossJ.F.Perivascular oxygen tensions in a transplantable mammary tumor growing in a dorsal flap window chamber. Radiat Res, 130, 171, 1992.
69.
tPalmerG.M., FontanellaA.N., ZhangG., HannaG., FraserC.L., and DewhirstM.W.Optical imaging of tumor hypoxia dynamics. J Biomed Opt, 15, 066021, 2010.
70.
JiangB.-H., SemenzaG.L., BauerC., and MartiH.H.Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol Cell Physiol, 271, C1172, 1996.
71.
KourembanasS., MarsdenP.A., McquillanL.P., and FallerD.V.Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest, 88, 1054, 1991.
72.
OgawaS., KogaS., KuwabaraK., BrettJ., MorrowB., MorrisS.A., BilezikianJ.P., SilversteinS.C., and SternD.Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cAMP levels. Am J Physiol Cell Physiol, 262, C546, 1992.
73.
SteinbrechD.S., MehraraB.J., SaadehP.B., GreenwaldJ.A., SpectorJ.A., GittesG.K., and LongakerM.T.Hypoxia increases insulinlike growth factor gene expression in rat osteoblasts. Ann Plast Surg, 44, 529, 2000.
74.
WangG.L., JiangB.-H., RueE.A., and SemenzaG.L.Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A, 92, 5510, 1995.
75.
SittingerM., BujiaJ., RotterN., ReitzelD., MinuthW.W., and BurmesterG.R.Tissue engineering and autologous transplant formation: practical approaches with resorbable biomaterials and new cell culture techniques. Biomaterials, 17, 237, 1996.
76.
GraysonW.L., BhumiratanaS., CannizzaroC., ChaoP.H.G., LennonD.P., CaplanA.I., and Vunjak-NovakovicG.Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Eng Part A, 14, 1809, 2008.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
